ESSA PHARMA INC.

Profile

Company Names

ESSA PHARMA INC.

Addresses

SUITE 720, 999 WEST BROADWAY, VANCOUVER, A1 V5Z 1K5

999 WEST BROADWAY, SUITE 720, VANCOUVER, A1 V5Z 1K5

SUITE 720, 999 WEST BROADWAY, VANCOUVER, A1 V5Z 1K5

Phone Numbers

(778) 331-0962

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$55,999,990.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2019-08-23 
$36,000,000.00 
$36,000,000.00 
$0.00 
Equity 
2
2016-03-21 
$4,999,998.00 
$4,999,998.00 
$0.00 
Equity 
1
2016-01-14 
$14,999,992.00 
$14,999,992.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RAYMOND 
 
ANDERSEN 
EXECUTIVE OFFICER, DIRECTOR
ESSA PHARMA INC.
FRANKLIN 
 
BERGER 
DIRECTOR
FIVE PRIME THERAPEUTICS INC   |  ITHERX PHARMA, INC.   |  IMMUNE DESIGN CORP.   |  ALZHEON, INC.   |  ATRECA, INC.   |  ESSA PHARMA INC.   |  CERUS ENDOVASCULAR LTD   |  KEZAR LIFE SCIENCES, INC.   |  BELLUS HEALTH INC.   |  APPLIED THERAPEUTICS INC.   |  ATEA PHARMACEUTICALS, INC.   |  RAIN THERAPEUTICS INC.   |  WALKING FISH THERAPEUTICS, INC.   |  SATELLOS BIOSCIENCE INC.
PAUL 
 
COSSUM 
EXECUTIVE OFFICER
ESSA PHARMA INC.
RICHARD 
 
GLICKMAN 
DIRECTOR
ESSA PHARMA INC.   |  EUPRAXIA PHARMACEUTICALS INC.
JOHN 
ALEX 
MARTIN 
DIRECTOR
ESSA PHARMA INC.
DAVID 
 
PARKINSON 
EXECUTIVE OFFICER, DIRECTOR
NODALITY INC   |  NODALITY, INC.   |  TRUSTWAVE HOLDINGS, INC.   |  ZYNGENIA, INC.   |  ESSA PHARMA INC.   |  REFUGE BIOTECHNOLOGIES, INC.   |  ANGIOCRINE BIOSCIENCE, INC.
FRANK 
 
PERABO 
EXECUTIVE OFFICER
ESSA PHARMA INC.
SCOTT 
 
REQUADT 
DIRECTOR
TYRX PHARMA INC   |  TYRX, INC.   |  CLARUS DEFINED EXIT I, L.P.   |  CLARUS DE II, L.P.   |  ESSA PHARMA INC.   |  AVROBIO, INC.   |  VBI VACCINES INC/BC   |  CLARUS IV-D, L.P.   |  CLARUS IV-C, L.P.   |  CLARUS IV-B, L.P.   |  CLARUS IV-A, L.P.   |  TALARIS THERAPEUTICS, INC.
MARIANNE 
 
SADAR 
EXECUTIVE OFFICER, DIRECTOR
ESSA PHARMA INC.
GARY 
 
SOLLIS 
DIRECTOR
ESSA PHARMA INC.
OTELLO 
 
STAMPACCHIA 
DIRECTOR
OMEGA FUND III, L.P.   |  OMEGA FUND II, L.P.   |  TREVI THERAPEUTICS, INC.   |  MORPHIC HOLDING, LLC   |  ESSA PHARMA INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  SCORPION THERAPEUTICS, INC.   |  IKENA ONCOLOGY, INC.   |  OMEGA FUND VIII, L.P.   |  THIRD ARC BIO, INC.
ANN 
MARELLA 
THORELL 
DIRECTOR
ESSA PHARMA INC.
PETER 
 
VIRSIK 
EXECUTIVE OFFICER
ESSA PHARMA INC.
DAVID 
 
WOOD 
EXECUTIVE OFFICER
HUMAN TOUCH, LLC   |  INTERACTIVE HEALTH FINANCE CORP.   |  INTERACTIVE HEALTH, INC.   |  DARFORD INTERNATIONAL INC.   |  CELATOR PHARMACEUTICALS INC   |  MAKETHEALIST, INC.   |  CAPTEK TOPCO, INC.   |  ESSA PHARMA INC.   |  CATALYST ORTHOSCIENCE LLC   |  CATALYST ORTHOSCIENCE INC   |  SPINETHERA, INC.   |  LILIS ENERGY, INC.   |  NEPRA FOODS, LTD.   |  HINGE HEALTH, INC.   |  NEPRA FOODS INC.   |  EXCISION MEDICAL, INC.   |  EXPERIC, LLC   |  AORTIC SOLUTIONS, INC.
SANDY 
 
ZWEIFACH 
DIRECTOR
ESSA PHARMA INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-08-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-08-23 
2016-04-01
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2016-03-21 
2016-01-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2016-01-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
OPPENHEIMER + CO. INC.
249
NONE
NONE
BLOOM BURTON + CO.
NONE
NONE
NONE
CANACCORD GENUITY INC.
1020
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
15407